Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
2021 · Cell Reports Medicine · 299 citations
https://doi.org/10.1016/j.xcrm.2021.100287
M
Molly Thomas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
3.9K
Citations
26
h-index
41
i10-index
Molly Thomas is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Plant biochemistry and biosynthesis & COVID-19 Clinical Research Studies. The author has an h-index of 26, co-authored 99 publications.
ORCID: 0000-0002-1393-6559Papers by this author
worksProfound Treg perturbations correlate with COVID-19 severity
2021 · Proceedings of the National Academy of Sciences · 162 citations
https://doi.org/10.1073/pnas.2111315118
Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
2018 · The Oncologist · 102 citations
https://doi.org/10.1634/theoncologist.2018-0174
Immune responses in checkpoint myocarditis across heart, blood and tumour
2024 · Nature · 41 citations
https://doi.org/10.1038/s41586-024-08105-5
386 SINGLE CELL DISSECTION OF CHECKPOINT INHIBITOR AND AUTOIMMUNE HEPATITIS REVEALS INSIGHTS INTO IMMUNE TOLERANCE IN THE HUMAN LIVER
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)00694-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat